Discovering The Potential of ZNF155 as A Drug Target Or Biomarker
Discovering The Potential of ZNF155 as A Drug Target Or Biomarker
ZNF155 (ZNF155 variant 5) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF155 is a transcription factor, which means it regulates the activity of other genes by binding to their DNA.
The ZNF155 gene was first identified in 2009 as a potential gene that could serve as a drug target for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. This was based on the fact that the ZNF155 gene was expressed in the brains of individuals with these conditions, and that it was highly expressed in the brains of individuals with family history of these conditions.
Since then, further research has suggested that ZNF155 may also be a potential biomarker for these diseases. For example, studies have shown that individuals with Alzheimer's disease and Parkinson's disease have lower levels of ZNF155 in their brains compared to healthy individuals. Additionally, ZNF155 has has been shown to be highly expressed in the brains of individuals with Huntington's disease, a genetic disorder that affects movement.
In addition to its potential as a drug target or biomarker, ZNF155 is also of interest as a potential therapeutic target for other diseases. For example, ZNF155 has been shown to be involved in the development and progression of cancer, and may be a useful target for cancer therapies. Additionally, ZNF155 has been shown to be involved in the regulation of inflammation, and may be a useful target for treatments for autoimmune disorders.
Overall, ZNF155 is a promising gene as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its potential and to develop effective treatments based on it.
Protein Name: Zinc Finger Protein 155
Functions: May be involved in transcriptional regulation
The "ZNF155 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF155 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3
